Sat 28 Nov 2009 | 11:41 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Nektar Therapeutics

Nektar Therapeutics (NKTR.O) (Nasdaq)
sector: Healthcare . industry: Biotechnology ยท View NKTR on other exchanges
As of  27 Nov 2009
8.61USD
Price Change
-0.31
Percent Change
-3.48%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Thomsen, Jillian 43 2008 Vice President - Finance, Chief Accounting Officer
Labrucherie, Gil 37 2007 Senior Vice President, General Counsel, Secretary
Moreadith, Randall 55 2008 Senior Vice President - Drug Development, Chief Development Officer
Robin, Howard 56 2007 President, Chief Executive Officer, Director
Whitfield, Roy 55 2000 Director
Kuebler, Christopher 55 2001 Director
Brown, Michael 50 2002 Director
Wang, Susan 58 2003 Director
Krivulka, Joseph 57 2005 Director
Huh, Hoyoung 39 2008 Director
Lingnau, Lutz 66 2007 Director
Chowrira, Bharatt 43 2008 Chief Operating Officer, Senior Vice President
Masuoka, Lorianne -- 2009 Chief Medical Officer
Nicholson, John 57 2007 Chief Financial Officer, Senior Vice President
Chess, Robert 52 2007 Chairman of the Board